RSV Vaccines: ACIP Recommendations For Adults Younger Than Age 60 Await More Data

Retrieved on: 2024-11-08 21:55:08

Tags for this article:

Click the tags to see associated articles and topics

RSV Vaccines: ACIP Recommendations For Adults Younger Than Age 60 Await More Data. View article details on hiswai:

Excerpt

GSK's Arexvy and Pfizer's Abrysvo are FDA-approved for individuals younger than 60 years old, but CDC's Advisory Committee on Immunization ...

Article found on: pink.pharmaintelligence.informa.com